SBIR/STTR Research Award

DRUG DISCOVERY PLATFORM FOR PROTEIN ARGININE METHYLTRANSFERASE INHIBITORS

Award identifier a86a51fdc543942b2e867b251f7829e1196b39093c9c2b99a4afdee477891865Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$157,500

Program and phase

STTR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CH3 BIOSYSTEMS, LLC
Proposal award date
2016-09-01
Contract end date
2018-08-31
UEI
P1JCCJZ44L76
Solicitation number
PA15-270
Topic code
300

Research abstract

Project Summary Abstract The long term objective of this project is the generation of a universal drug discovery platform based on protein arginine methylation mechanisms involved in human disease The importance of protein arginine methylation in the context of human disease has become clear in the last few years with the realization that protein arginine methyltransferases and the target proteins for these enzymes are a rich source of potential therapeutic targets The specific aims of the project are to produce a general high throughput screening method for identifying potent inhibitors of protein arginine methyltransferases and to generate the means for isolating and identifying cellular methylarginine proteins for the purpose of determining the methylation status of specific proteins The methods include a combination of high throughput screening of enzyme inhibitors and biochemical immunological biophysical and cell biology techniques to isolate identify quantify and characterize methylarginine protein biomarkers The final phase of the project will analyze the methylarginine proteins of human blood cells drawn from normal volunteers and patients diagnosed with the autoimmune disease scleroderma This research is relevant to millions of Americans afflicted with autoimmune disorders as well as neurodevelopmental syndromes and viral neoplastic and cardiovascular disease Elucidation of the role of protein arginine methylation in these diseases holds promise for better diagnosis understanding and treatment of health related problems Project Narrative The purpose of this project is the development of a commercial technology that will facilitate the discovery screening and further testing of new first in class drugs There are at least five areas of medicine that are likely to be impacted by the technology autoimmune disorders neurodevelopmental syndromes and viral neoplastic and cardiovascular diseases The long term goal of the project is better diagnosis understanding and treatment of health related problems by promoting more rapid advances in Randamp D and molecular diagnostics

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.